Candel Therapeutics (CADL) Operating Leases (2022 - 2025)
Candel Therapeutics (CADL) posted Operating Leases of $1.5 million for Q4 2025, down 7.19% sequentially from $1.6 million in Q3 2025, and up 258.48% YoY from $407000.0 in Q4 2024.
Candel Therapeutics (CADL) Operating Leases (2022 - 2025) Analysis & Trends
Candel Therapeutics has reported Operating Leases for 4 years, with the latest figure at $1.5 million in Q4 2025.
- Quarterly Operating Leases rose 258.48% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (up 258.48% YoY) and the FY2025 annual result came in at $1.5 million, up 258.48% from the prior year.
- Operating Leases fell to $1.5 million in Q4 2025 per CADL's latest filing, from $1.6 million in the prior quarter.
- Over five years, Operating Leases peaked at $1.8 million in Q1 2022 and troughed at $104000.0 in Q2 2025.
- A 4-year average of $1.1 million and a median of $1.2 million in 2023 frame the typical range for Operating Leases.
- The widest YoY moves for Operating Leases: up 258.48% in 2025, down 85.1% in 2025.
- Over 4 years, Operating Leases stood at $1.5 million in 2022, then sank by 34.52% to $973000.0 in 2023, then plunged by 58.17% to $407000.0 in 2024, then jumped by 258.48% to $1.5 million in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $1.5 million, $1.6 million, and $104000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 257,000.00 |
| Dec 31, 2024 | 407,000.00 |
| Sep 30, 2024 | 555,000.00 |
| Jun 30, 2024 | 698,000.00 |
| Mar 31, 2024 | 837,000.00 |
| Dec 31, 2023 | 973,000.00 |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.49 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | 1.84 Mn |